Axsome Therapeutics, Inc (AXSM) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for AXSM. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 494 institutions reported holding AXSM, with 38.1 million shares worth $9.3 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Vanguard | 4,299,070 | $1.1B | DECREASED |
| BlackRock | 3,103,708 | $760M | DECREASED |
| Invesco Ltd | 1,671,684 | $409M | INCREASED |
| FMR | 1,539,163 | $377M | DECREASED |
| Geode Capital Management | 967,172 | $237M | DECREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Mark L. Jacobson (Chief Operating Officer) | EXERCISE | 10,000 | $130K | 2026-09-03 |
| Mark L. Jacobson (Chief Operating Officer) | SELL | 10,000 | $2M | 2026-09-03 |
| Mark L. Jacobson (Chief Operating Officer) | EXERCISE | 10,000 | $130K | 2026-09-03 |
Full institutional holdings, insider history, and congressional trades for Axsome Therapeutics, Inc on SentiSense.